Russian start-up gets rights to develop and commercialise Roche HIV treatments Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan. 14 Oct 2009 News
Will Roche get what it paid for? Beyond its blockbuster drugs Genentech has a commodity rare in a large company – an entrepreneurial culture. Can Roche preserve this? 18 Mar 2009 News